imiloxan has been researched along with trioxsalen in 1 studies
Studies (imiloxan) | Trials (imiloxan) | Recent Studies (post-2010) (imiloxan) | Studies (trioxsalen) | Trials (trioxsalen) | Recent Studies (post-2010) (trioxsalen) |
---|---|---|---|---|---|
45 | 0 | 21 | 520 | 16 | 39 |
Protein | Taxonomy | imiloxan (IC50) | trioxsalen (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.356 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.831 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.356 | |
Adenosine receptor A2a | Homo sapiens (human) | 1.312 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for imiloxan and trioxsalen
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |